New at WaveTec

Article

Thomas G. Frinzi is to become company President and Chief Executive Officer at WaveTec Vision. He replaces Tom Berryman who after a period of transition will be leaving the company to pursue other entrepreneurial ventures.

Thomas G. Frinzi is to become company President and Chief Executive Officer at WaveTec Vision. He replaces Tom Berryman who after a period of transition will be leaving the company to pursue other entrepreneurial ventures.

“The board appreciates Tom Berryman’s leadership and great contribution to the company's achievements, as well as his role in recruiting Tom Frinzi to the company. We are enormously pleased to welcome Tom to WaveTec,”said Charles Warden, of Versant Ventures a board member and investor in WaveTec. “Tom is a seasoned and dynamic leader who brings a wealth of proven commercial experience within the ophthalmic space. ”

Frinzi who began his career at Johnson & Johnson, is a 30 year veteran of the ophthalmic and medical device industries. Most recently, he served as Vice President of Global Commercial Operations at Bausch+Lomb Surgical where he was responsible for worldwide revenue of approximately $500 million generated via their cataract and vitreo‐retinal product portfolio.

“What attracted me to WaveTec is the potential to change the landscape of cataract surgery,” said Mr Frinzi. “What cornea topography was to refractive surgery, ORange can be to cataract surgery. The Premium Channel has raised expectations and WaveTec is uniquely positioned to help surgeons optimize their outcomes and ultimately improve the overall patient experience. That's exciting.”

Related Videos
Josefina Botta, MD, MSc, at ASCRS 2024
Dr Nir Shoham Hazon, Director, Miramichi EyeNB Centre of Excellence, New Brunswick, Canada
J. Morgan Micheletti, MD, speaks at the 2024 ASCRS meeting
Dr William Wiley of Cleveland Eye Clinic, Northeast Ohio
© 2024 MJH Life Sciences

All rights reserved.